Assetmark Inc. Raises Holdings in Omega Healthcare Investors, Inc. $OHI

Assetmark Inc. lifted its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 7.2% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,340,503 shares of the real estate investment trust’s stock after buying an additional 90,507 shares during the period. Assetmark Inc. owned about 0.46% of Omega Healthcare Investors worth $49,129,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in OHI. AQR Capital Management LLC boosted its position in shares of Omega Healthcare Investors by 430.8% during the 1st quarter. AQR Capital Management LLC now owns 2,862,117 shares of the real estate investment trust’s stock worth $108,989,000 after purchasing an additional 2,322,878 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of Omega Healthcare Investors by 3.9% in the 1st quarter. Vanguard Group Inc. now owns 39,554,886 shares of the real estate investment trust’s stock worth $1,506,250,000 after acquiring an additional 1,492,904 shares during the period. Invesco Ltd. grew its holdings in shares of Omega Healthcare Investors by 122.3% in the 1st quarter. Invesco Ltd. now owns 2,416,560 shares of the real estate investment trust’s stock worth $92,023,000 after acquiring an additional 1,329,324 shares during the period. Nuveen LLC acquired a new stake in shares of Omega Healthcare Investors in the 1st quarter worth approximately $42,513,000. Finally, Caisse DE Depot ET Placement DU Quebec grew its holdings in shares of Omega Healthcare Investors by 163.5% in the 1st quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,371,945 shares of the real estate investment trust’s stock worth $52,244,000 after acquiring an additional 851,299 shares during the period. 65.25% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Omega Healthcare Investors news, Director Lisa Egbuonu-Davis sold 2,500 shares of the stock in a transaction on Friday, August 8th. The stock was sold at an average price of $40.16, for a total value of $100,400.00. Following the sale, the director directly owned 18,654 shares of the company’s stock, valued at $749,144.64. This trade represents a 11.82% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.50% of the stock is owned by corporate insiders.

Omega Healthcare Investors Stock Performance

Omega Healthcare Investors stock opened at $39.91 on Friday. Omega Healthcare Investors, Inc. has a 52 week low of $35.04 and a 52 week high of $44.42. The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96. The stock has a 50 day moving average of $41.47 and a 200-day moving average of $39.08. The stock has a market cap of $11.77 billion, a P/E ratio of 24.64, a price-to-earnings-growth ratio of 1.85 and a beta of 0.70.

Omega Healthcare Investors (NYSE:OHI) last issued its earnings results on Thursday, October 30th. The real estate investment trust reported $0.79 earnings per share for the quarter, topping the consensus estimate of $0.77 by $0.02. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The firm had revenue of $260.74 million for the quarter, compared to analyst estimates of $262.48 million. During the same period last year, the company earned $0.71 earnings per share. The firm’s revenue for the quarter was up 14.4% on a year-over-year basis. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS. On average, analysts expect that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, November 17th. Shareholders of record on Monday, November 3rd will be given a $0.67 dividend. The ex-dividend date of this dividend is Monday, November 3rd. This represents a $2.68 annualized dividend and a yield of 6.7%. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 165.43%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. Scotiabank upped their price target on Omega Healthcare Investors from $39.00 to $42.00 and gave the stock a “sector perform” rating in a report on Thursday, August 28th. Wells Fargo & Company boosted their target price on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the company an “overweight” rating in a research note on Tuesday, October 21st. Raymond James Financial reissued an “outperform” rating on shares of Omega Healthcare Investors in a research note on Tuesday, September 2nd. Cantor Fitzgerald began coverage on Omega Healthcare Investors in a report on Wednesday, October 1st. They set an “overweight” rating and a $50.00 price objective on the stock. Finally, Mizuho raised their price objective on Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a “neutral” rating in a report on Thursday, September 11th. Five research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $43.86.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.